Inovio Pharmaceuticals, Inc.
INO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001055726
No open-market purchases or sales by Inovio Pharmaceuticals, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $36.1M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Inovio Pharmaceuticals, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 101 | 3 | 99 | +1 |
| Shares | 33.0M | 3.37M | 31.4M | +1.70M (+5.7%) |
| Value | $57.5M | $5.86M | $54.6M | +$2.99M (+5.8%) |
3 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 2,901,208 | $5.05M | 0.00% |
| Eversept Partners, LP | 1,035,360 | $1.80M | 0.12% |
| Vanguard Fiduciary Trust Co | 392,066 | $682.2K | 0.00% |
| Citadel Advisors LLC | 286,352 | $498.3K | 0.00% |
| GMT Capital Corp | 126,119 | $219.4K | 0.01% |
| Tower Research Capital LLC (TRC) | 55,491 | $96.6K | 0.00% |
| CIBC Bancorp USA Inc. | 50,000 | $87.0K | 0.00% |
| IMC-Chicago, LLC | 37,889 | $65.9K | 0.00% |
| Vanguard Global Advisers, LLC | 30,235 | $52.6K | 0.00% |
| Nine Masts Capital Ltd | 26,317 | $45.8K | 0.01% |
| Squarepoint Ops LLC | 24,837 | $43.2K | 0.00% |
| Diametric Capital, LP | 24,491 | $42.6K | 0.01% |
| HRT Financial LP | 12,917 | $22.0K | 0.00% |
| VSM Wealth Advisory, LLC | 250 | $435 | 0.00% |
| Silver Grove Financial Group, Inc. | 5 | $9 | 0.00% |
| HM Payson & Co | 2 | $4 | 0.00% |
Sold out (15)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Omers Administration Corp | 223,000 | $388.0K |
| Jacobs Levy Equity Management, Inc | 130,792 | $227.6K |
| Two Sigma Advisers, LP | 73,701 | $128.2K |
| Hudson Bay Capital Management LP | 50,677 | $88.2K |
| Virtu Financial LLC | 44,040 | $77.0K |
| Quadrature Capital Ltd | 37,222 | $64.8K |
| Concurrent Investment Advisors, LLC | 36,011 | $62.7K |
| Lighthouse Investment Partners, LLC | 30,600 | $53.2K |
| Wolverine Asset Management LLC | 30,500 | $53.1K |
| Baader Bank INC | 36,767 | $39.5K |
| Bank of Montreal | 17,382 | $30.2K |
| Federated Hermes, Inc. | 1,722 | $3.00K |
| SRS Capital Advisors, Inc. | 103 | $179 |
| IFP Advisors, Inc | 14 | $24 |
| Strive Financial Group ,LLC | 1 | $2 |
Not filed for Q1 2026 yet (3)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 3,315,580 | $5.77M |
| CIBC Private Wealth Group, LLC | 50,000 | $87.0K |
| GPS Wealth Strategies Group, LLC | 4 | $7 |